Kang Hu
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Computational Drug Discovery Methods, Cholinesterase and Neurodegenerative Diseases, Drug Transport and Resistance Mechanisms, Neuroscience and Neuropharmacology Research
Most-Cited Works
- → Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse(1999)3,141 cited
- → Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease(2000)1,999 cited
- → High-Level Neuronal Expression of Aβ1–42in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation(2000)1,860 cited
- → Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models(1999)1,125 cited
- → Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brain(2001)877 cited
- → Amyloid precursor protein processing and Aβ 42 deposition in a transgenic mouse model of Alzheimer disease(1997)656 cited
- → Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology(2003)406 cited
- → Aβ42 immunization in Alzheimer's disease generates Aβ N-terminal antibodies(2005)129 cited
- → Identification of γ-Secretase Inhibitor Potency Determinants on Presenilin(2007)61 cited
- → Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease(2010)50 cited